Tubach F - Search Results

1

IgG anti-beta2-glycoprotein I antibodies in adult patients with systemic lupus erythematosus: prevalence and diagnostic value for the antiphospholipid syndrome.

Tubach F, Hayem G, Marchand JL, Weber M, Palazzo E, de Bandt M, Roux S, Kahn MF, Meyer O. Tubach F, et al. J Rheumatol. 2000 Jun;27(6):1437-43. J Rheumatol. 2000. PMID: 10852267

2

Anticentromere antibodies in rheumatologic practice are not consistently associated with scleroderma.

Tubach F, Hayem G, Elias A, Nicaise P, Haim T, Kahn MF, Meyer O. Tubach F, et al. Rev Rhum Engl Ed. 1997 Jun;64(6):362-7. Rev Rhum Engl Ed. 1997. PMID: 9513607

3

SLE in black patients from Africa and the French West Indies. Spectrum and race differences.

Eti E, Hayem G, De Bandt M, Tubach F, Palazzo E, Kahn MF, Meyer O. Eti E, et al. Among authors: tubach f. Clin Exp Rheumatol. 1998 Nov-Dec;16(6):762-3. Clin Exp Rheumatol. 1998. PMID: 9844780 No abstract available.

4

Anti-oxidized low-density-lipoprotein (OxLDL) antibodies in systemic lupus erythematosus with and without antiphospholipid syndrome.

Hayem G, Nicaise-Roland P, Palazzo E, de Bandt M, Tubach F, Weber M, Meyer O. Hayem G, et al. Among authors: tubach f. Lupus. 2001;10(5):346-51. doi: 10.1191/096120301667475689. Lupus. 2001. PMID: 11403265

5

Minimal clinically important difference, low disease activity state, and patient acceptable symptom state: methodological issues.

Tubach F, Wells GA, Ravaud P, Dougados M. Tubach F, et al. J Rheumatol. 2005 Oct;32(10):2025-9. J Rheumatol. 2005. PMID: 16206363 Review.

6

Anti-RNA polymerase III antibody prevalence and associated clinical manifestations in a large series of French patients with systemic sclerosis: a cross-sectional study.

Meyer O, De Chaisemartin L, Nicaise-Roland P, Cabane J, Tubach F, Dieude P, Hayem G, Palazzo E, Chollet-Martin S, Kahan A, Allanore Y. Meyer O, et al. Among authors: tubach f. J Rheumatol. 2010 Jan;37(1):125-30. doi: 10.3899/jrheum.090677. Epub 2009 Nov 16. J Rheumatol. 2010. PMID: 19918031

7

High levels of anti-cyclic citrullinated peptide autoantibodies are associated with co-occurrence of pulmonary diseases with rheumatoid arthritis.

Aubart F, Crestani B, Nicaise-Roland P, Tubach F, Bollet C, Dawidowicz K, Quintin E, Hayem G, Palazzo E, Meyer O, Chollet-Martin S, Dieudé P. Aubart F, et al. Among authors: tubach f. J Rheumatol. 2011 Jun;38(6):979-82. doi: 10.3899/jrheum.101261. Epub 2011 Mar 1. J Rheumatol. 2011. PMID: 21362759

8

Body mass index influences the response to infliximab in ankylosing spondylitis.

Ottaviani S, Allanore Y, Tubach F, Forien M, Gardette A, Pasquet B, Palazzo E, Meunier M, Hayem G, Job-Deslandre C, Kahan A, Meyer O, Dieudé P. Ottaviani S, et al. Among authors: tubach f. Arthritis Res Ther. 2012 May 14;14(3):R115. doi: 10.1186/ar3841. Arthritis Res Ther. 2012. PMID: 22584116 Free PMC article.

9

25-hydroxyvitamin D status does not affect the clinical rituximab response in rheumatoid arthritis.

M'Barek RB, Dupré T, Tubach F, Dieudé P, Palazzo E, Hayem G, Dawidowicz K, Ottaviani S, Alfaiate T, Leçon-Malais V, Boutten A, Meyer O. M'Barek RB, et al. Among authors: tubach f. Joint Bone Spine. 2014 Jan;81(1):96-7. doi: 10.1016/j.jbspin.2013.04.017. Epub 2013 Jun 21. Joint Bone Spine. 2014. PMID: 23796732 No abstract available.

10

High anti-CCP antibody titres predict good response to rituximab in patients with active rheumatoid arthritis.

Gardette A, Ottaviani S, Tubach F, Roy C, Nicaise-Roland P, Palazzo E, Gill G, Meyer O, Dieudé P. Gardette A, et al. Among authors: tubach f. Joint Bone Spine. 2014 Oct;81(5):416-20. doi: 10.1016/j.jbspin.2014.06.001. Epub 2014 Jul 3. Joint Bone Spine. 2014. PMID: 24998790

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

324 results

Search Page

Filters